Q BioMed (QBIO) rising after CEO’s interview. Says firm’s drug hitting markets ahead of schedule.  #daytrader #daytrading #Investment #StockMarket #stocks #stockstowatch #trading #options #investing #pennystocks #biotech #cancer #FDA https://t.co/6WjCYmwE5G